{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:59:02Z","timestamp":1787018342666,"version":"build-2736575974"},"reference-count":41,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"3","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trans. Vis. Sci. Tech."],"published-print":{"date-parts":[[2026,3,3]]},"DOI":"10.1167\/tvst.15.3.5","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T13:30:33Z","timestamp":1772544633000},"page":"5","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and Safety of Gene Therapy for RPGR Gene-Associated X-Linked Retinitis Pigmentosa: A Systematic Review and Meta-Analysis"],"prefix":"10.1167","volume":"15","author":[{"given":"Jiaqi","family":"Yang","sequence":"first","affiliation":[{"name":"Xiangya School of Medicine, Central South University, Changsha, Hunan, People's Republic of China"},{"name":"Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China"},{"name":"National Clinical Research Center for Eye Diseases, Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiou","family":"Lei","sequence":"additional","affiliation":[{"name":"Xiangya School of Medicine, Central South University, Changsha, Hunan, People's Republic of China"},{"name":"Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China"},{"name":"National Clinical Research Center for Eye Diseases, Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingqing","family":"Xiao","sequence":"additional","affiliation":[{"name":"Xiangya School of Medicine, Central South University, Changsha, Hunan, People's Republic of China"},{"name":"Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China"},{"name":"National Clinical Research Center for Eye Diseases, Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[{"name":"Xiangya School of Medicine, Central South University, Changsha, Hunan, People's Republic of China"},{"name":"Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China"},{"name":"National Clinical Research Center for Eye Diseases, Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongwei","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China"},{"name":"National Clinical Research Center for Eye Diseases, Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Tong Ren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.preteyeres.2018.03.005","article-title":"Non-syndromic retinitis pigmentosa","volume":"66","author":"Verbakel","year":"2018","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"bib2","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1086\/379379","article-title":"RP2 and RPGR mutations and clinical correlations in patients with X-linked retinitis pigmentosa","volume":"73","author":"Sharon","year":"2003","journal-title":"Am J Hum Genet"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"100898","DOI":"10.1016\/j.preteyeres.2020.100898","article-title":"The X-linked retinopathies: physiological insights, pathogenic mechanisms, phenotypic features and novel therapies","volume":"82","author":"De Silva","year":"2021","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"bib4","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1167\/iovs.06-0971","article-title":"Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations","volume":"48","author":"Sandberg","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ajo.2024.11.021","article-title":"Subretinal gene therapy drug AGTC-501 for XLRP phase 1\/2 multicenter study (HORIZON): 24-month safety and efficacy results","volume":"271","author":"Yang","year":"2025","journal-title":"Am J Ophthalmol"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ajo.2024.05.034","article-title":"Phase 1\/2 AAV5-hRKp.RPGR (Botaretigene Sparoparvovec) gene therapy: safety and efficacy in RPGR-associated X-linked retinitis pigmentosa","volume":"267","author":"Michaelides","year":"2024","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"bib7","first-page":"2133","article-title":"Subretinal gene therapy AGTC-501 for X-linked retinitis pigmentosa in the phase 1\/2 Horizon study: post-hoc analysis of microperimetry results in the high dose groups","volume":"65","author":"Birch","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"bib8","first-page":"1479","article-title":"Visual function improvements with BIIB112 (NSR-RPGR) in X-linked retinitis pigmentosa: XIRIUS (dose-expansion) and XOLARIS (natural disease progression) studies","volume":"62","author":"MacLaren","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib9","doi-asserted-by":"crossref","first-page":"bmj.n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"3","key":"bib10","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/s41591-020-0763-1","article-title":"Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR","volume":"26","author":"Cehajic-Kapetanovic","year":"2020","journal-title":"Nat Med"},{"issue":"3","key":"bib11","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1001\/jamaophthalmol.2022.6254","article-title":"Changes in retinal sensitivity associated with cotoretigene toliparvovec in X-Linked Retinitis Pigmentosa With RPGR Gene Variations","volume":"141","author":"von Krusenstiern","year":"2023","journal-title":"JAMA Ophthalmol"},{"issue":"9","key":"bib12","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.ophtha.2024.02.023","article-title":"Assessment of visual function with cotoretigene toliparvovec in X-linked retinitis pigmentosa in the randomized XIRIUS phase 2\/3 study","volume":"131","author":"Lam","year":"2024","journal-title":"Ophthalmology"},{"issue":"1\u20132","key":"bib13","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41434-022-00353-2","article-title":"Clinical enrollment assay to detect preexisting neutralizing antibodies to AAV6 with demonstrated transgene expression in gene therapy trials","volume":"30","author":"Cao","year":"2023","journal-title":"Gene Ther"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.omtm.2022.10.014","article-title":"The seroprevalence of neutralizing antibodies against the adeno-associated virus capsids in Japanese hemophiliacs","volume":"27","author":"Kashiwakura","year":"2022","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"11","key":"bib15","doi-asserted-by":"publisher","first-page":"e0033522","DOI":"10.1128\/jvi.00335-22","article-title":"Characterization of the serpentine adeno-associated virus (SAAV) capsid structure: receptor interactions and antigenicity","volume":"96","author":"Mietzsch","year":"2022","journal-title":"J Virol"},{"issue":"1","key":"bib16","doi-asserted-by":"publisher","first-page":"101217","DOI":"10.1016\/j.omtm.2024.101217","article-title":"Preexisting antibody assays for gene therapy: considerations on patient selection cutoffs and companion diagnostic requirements","volume":"32","author":"Braun","year":"2024","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"3","key":"bib17","doi-asserted-by":"publisher","first-page":"e1607","DOI":"10.1002\/ctm2.1607","article-title":"Optimization strategies and advances in the research and development of AAV-based gene therapy to deliver large transgenes","volume":"14","author":"Kolesnik","year":"2024","journal-title":"Clin Transl Med"},{"issue":"1","key":"bib18","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1038\/s41467-022-30102-3","article-title":"Liver-directed lentiviral gene therapy corrects hemophilia A mice and achieves normal-range factor VIII activity in non-human primates","volume":"13","author":"Milani","year":"2022","journal-title":"Nat Commun"},{"issue":"3","key":"bib19","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.7150\/thno.89380","article-title":"Understanding AAV vector immunogenicity: from particle to patient","volume":"14","author":"Dhungel","year":"2024","journal-title":"Theranostics"},{"issue":"10","key":"bib20","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.3390\/genes14101866","article-title":"Bioengineered hybrid Rep 2\/6 gene improves encapsulation of a single-stranded expression cassette into AAV6 vectors","volume":"14","author":"Tejero","year":"2023","journal-title":"Genes (Basel)"},{"issue":"4","key":"bib21","doi-asserted-by":"publisher","first-page":"106487","DOI":"10.1016\/j.isci.2023.106487","article-title":"Adeno-associated virus vector system controlling capsid expression improves viral quantity and quality","volume":"26","author":"Ohba","year":"2023","journal-title":"iScience"},{"issue":"5","key":"bib22","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.3390\/ijms25052785","article-title":"A direct comparison of rAAV5 variants derived from the baculovirus expression system using LC-MS workflows demonstrates key differences in overall production yield, product quality and vector efficiency","volume":"25","author":"Guapo","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"1","key":"bib23","doi-asserted-by":"publisher","first-page":"101416","DOI":"10.1016\/j.omtm.2025.101416","article-title":"Development of cell lines with increased susceptibility to diverse adeno-associated viral vectors to enable in vitro potency assays","volume":"33","author":"Zengel","year":"2025","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"3","key":"bib24","doi-asserted-by":"publisher","first-page":"898","DOI":"10.3390\/jcm14030898","article-title":"Pre-clinical and clinical advances in gene therapy of X-linked retinitis pigmentosa: hope on the horizon","volume":"14","author":"Pechnikova","year":"2025","journal-title":"J Clin Med"},{"issue":"11","key":"bib25","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1167\/tvst.12.11.24","article-title":"Safety and efficacy of adeno-associated viral gene therapy in patients with retinal degeneration: a systematic review and meta-analysis","volume":"12","author":"Sobh","year":"2023","journal-title":"Transl Vis Sci Technol"},{"issue":"12","key":"bib26","doi-asserted-by":"publisher","first-page":"a041291","DOI":"10.1101\/cshperspect.a041291","article-title":"Developing new vectors for retinal gene therapy","volume":"13","author":"Zin","year":"2023","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"9","key":"bib27","doi-asserted-by":"publisher","first-page":"e2411062","DOI":"10.1002\/advs.202411062","article-title":"Artificial intelligence-based approaches for AAV vector engineering","volume":"12","author":"Tan","year":"2025","journal-title":"Adv Sci (Weinh)"},{"issue":"5","key":"bib28","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.tibs.2024.03.002","article-title":"Computationally guided AAV engineering for enhanced gene delivery","volume":"49","author":"Guo","year":"2024","journal-title":"Trends Biochem Sci"},{"issue":"29","key":"bib29","doi-asserted-by":"publisher","first-page":"13820","DOI":"10.1039\/D4NR01300J","article-title":"Chemical approaches to probe and engineer AAV vectors","volume":"16","author":"Pham","year":"2024","journal-title":"Nanoscale"},{"issue":"9\u201310","key":"bib30","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1089\/hum.2024.022","article-title":"Development of AAV-mediated gene therapy approaches to treat skeletal diseases","volume":"35","author":"Lin","year":"2024","journal-title":"Hum Gene Ther"},{"issue":"2","key":"bib31","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.jhep.2023.10.029","article-title":"Adeno-associated viruses for gene therapy - clinical implications and liver-related complications, a guide for hepatologists","volume":"80","author":"M\u00fccke","year":"2024","journal-title":"J Hepatol"},{"issue":"1","key":"bib32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1021\/acssynbio.2c00589","article-title":"Synthetic biology design as a paradigm shift toward manufacturing affordable adeno-associated virus gene therapies","volume":"12","author":"Collins","year":"2023","journal-title":"ACS Synth Biol"},{"issue":"1","key":"bib33","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/14712598.2020.1680635","article-title":"RPGR gene therapy presents challenges in cloning the coding sequence","volume":"20","author":"Martinez-Fernandez De La Camara","year":"2020","journal-title":"Expert Opin Biol Ther"},{"issue":"9","key":"bib34","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1089\/hum.2015.035","article-title":"Stability and safety of an AAV vector for treating RPGR-ORF15 X-linked retinitis pigmentosa","volume":"26","author":"Deng","year":"2015","journal-title":"Hum Gene Ther"},{"issue":"8","key":"bib35","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1016\/j.ymthe.2017.05.004","article-title":"Optimization of retinal gene therapy for X-linked retinitis pigmentosa due to RPGR mutations","volume":"25","author":"Beltran","year":"2017","journal-title":"Mol Ther"},{"issue":"49","key":"bib36","doi-asserted-by":"publisher","first-page":"e2208707119","DOI":"10.1073\/pnas.2208707119","article-title":"Impaired glutamylation of RPGR(ORF15) underlies the cone-dominated phenotype associated with truncating distal ORF15 variants","volume":"119","author":"Cehajic-Kapetanovic","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"bib37","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.3390\/ijms25031839","article-title":"AAV-RPGR gene therapy rescues opsin mislocalisation in a human retinal organoid model of RPGR-associated X-linked retinitis pigmentosa","volume":"25","author":"Sladen","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"10","key":"bib38","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1016\/j.drudis.2021.04.020","article-title":"The impact of COVID-19 on the cell and gene therapies industry: disruptions, opportunities, and future prospects","volume":"26","author":"Qiu","year":"2021","journal-title":"Drug Discov Today"},{"issue":"1","key":"bib39","first-page":"19","article-title":"Impact of the COVID-19 pandemic on non-COVID-19 clinical trials","volume":"9","author":"Audisio","year":"2022","journal-title":"J Cardiovasc Dev Dis"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"55","DOI":"10.12688\/hrbopenres.13283.1","article-title":"The impact of COVID-19 on clinical research: the PIPPRA and MEDRA experience","volume":"4","author":"Larkin","year":"2021","journal-title":"HRB Open Res"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"4244740","DOI":"10.1155\/joph\/4244740","article-title":"Early-onset cone photoreceptor degeneration is associated with high myopia in RPGR-related retinal dystrophy","volume":"2025","author":"Raji","year":"2025","journal-title":"J Ophthalmol"}],"container-title":["Translational Vision Science & Technology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/tvst.arvojournals.org\/article.aspx?doi=10.1167\/tvst.15.3.5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T13:30:34Z","timestamp":1772544634000},"score":1,"resource":{"primary":{"URL":"http:\/\/tvst.arvojournals.org\/article.aspx?doi=10.1167\/tvst.15.3.5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,2]]}},"URL":"https:\/\/doi.org\/10.1167\/tvst.15.3.5","relation":{},"ISSN":["2164-2591"],"issn-type":[{"value":"2164-2591","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,3]]}}}